Bovine lactoferrin and lactoferricin, a peptide derived from bovine lactoferrin, inhibit tumor metastasis in mice

被引:179
|
作者
Yoo, YC [1 ]
Watanabe, S [1 ]
Watanabe, R [1 ]
Hata, K [1 ]
Shimazaki, K [1 ]
Azuma, I [1 ]
机构
[1] HOKKAIDO UNIV, FAC AGR, DEPT DAIRY SCI, KITA KU, SAPPORO, HOKKAIDO 060, JAPAN
来源
JAPANESE JOURNAL OF CANCER RESEARCH | 1997年 / 88卷 / 02期
关键词
bovine lactoferrin; bovine lactoferricin; host defense; tumor metastasis; antitumor activity;
D O I
10.1111/j.1349-7006.1997.tb00364.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We investigated the effect of a bovine milk protein, lactoferrin (LF-B), and a pepsin-generated peptide of LF-B, lactoferricin (Lfcin-B), on inhibition of tumor metastasis produced by highly metastatic murine tumor cells, B16-BL6 melanoma and L5178Y-ML25 lymphoma cells, using experimental and spontaneous metastasis models in syngeneic mice. The subcutaneous (s.c.) administration of bovine apo-lactoferrin (apo-LF-B, 1 mg/mouse) and Lfcin-B (0.5 mg/mouse) 1 day after tumor inoculation significantly inhibited liver and lung metastasis of L5178Y-ML25 cells, However, human apo-lactoferrin (apo-LF-H) and bovine holo-lactoferrin (holo-LF-B) at the dose of 1 mg/mouse failed to inhibit tumor metastasis of L5178Y-ML25 cells. Similarly, the s.c. administration of apo-LF-B as well as Lfcin-B, but not apo-LF-H and holo-LF-B, 1 day after tumor inoculation resulted in significant inhibition of lung metastasis of B16-BL6 cells in an experimental metastasis model, Furthermore, in in vivo analysis for tumor-induced angiogenesis, both apo-LF-B and Lfcin-B inhibited the number of tumor-induced blood vessels and suppressed tumor growth on day 8 after tumor inoculation, However, in a long-term analysis of tumor growth for up to 21 days after tumor inoculation, single administration of apo-LF-B significantly suppressed the growth of B16-BL6 cells throughout the examination period, whereas Lfcin-B showed inhibitory activity only during the early period (8 days), In spontaneous metastasis of B16-BL6 melanoma cells, multiple administration of both apo-LF-B and Lfcin-B into tumor-bearing mice significantly inhibited lung metastasis produced by B16-BL6 cells, though only apo-LF-B exhibited an inhibitory effect on tumor growth at the time of primary tumor amputation (on day 21) after tumor inoculation. These results suggest that apo-LF-B and Lfcin-B inhibit tumor metastasis through different mechanisms, and that the inhibitory activity of LF-B on tumor metastasis may be related to iron (Fe2+)-saturation.
引用
收藏
页码:184 / 190
页数:7
相关论文
共 50 条
  • [21] LETTER: DOES BOVINE LACTOFERRIN INHIBIT HELICOBACTER PYLORI?
    Charu Joshi
    Naiyana Wattanapenpaiboon
    Mark L. Wahlqvist
    Peter Midolo
    John Lambert
    Digestive Diseases and Sciences, 2001, 46 : 1011 - 1012
  • [22] Isolation of a Bifidogenic Peptide from the Pepsin Hydrolysate of Bovine Lactoferrin
    Oda, Hirotsugu
    Wakabayashi, Hiroyuki
    Yamauchi, Koji
    Sato, Takumi
    Xiao, Jin-Zhong
    Abe, Fumiaki
    Iwatsuki, Keiji
    APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2013, 79 (06) : 1843 - 1849
  • [23] Influence of bovine lactoferrin and lactoferricin on cytokine expression in LPS-treated cultivated bovine blood cells
    Prgomet, C
    Peters, S
    Pfaffl, MW
    JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE, 2006, 86 (04) : 640 - 647
  • [24] Inhibitory effects of bovine lactoferrin on colon carcinoma 26 lung metastasis in mice
    Iigo, M
    Kuhara, T
    Ushida, Y
    Sekine, K
    Moore, MA
    Tsuda, H
    CLINICAL & EXPERIMENTAL METASTASIS, 1999, 17 (01) : 35 - 40
  • [25] Inhibitory effects of bovine lactoferrin on colon carcinoma 26 lung metastasis in mice
    Masaaki Iigo
    Tetsuya Kuhara
    Yoshihiko Ushida
    Kazunori Sekine
    Malcolm A. Moore
    Hiroyuki Tsuda
    Clinical & Experimental Metastasis, 1999, 17 (1) : 43 - 49
  • [26] Safety and Antibacterial Mechanism of Bovine Lactoferrin Derived Peptide FP-PF
    Fu Y.
    Li Y.
    Jiang Z.
    Liu F.
    Jiang C.
    Hou J.
    Tian B.
    Wang Y.
    Journal of Chinese Institute of Food Science and Technology, 2020, 20 (08) : 92 - 99
  • [27] Antimicrobial activity of recombinant bovine lactoferrin and lactoferricin B and glycosylated human lysozyme
    El-Sayed, EM
    Mahfouz, MB
    Abdelsalam, AM
    El Gawad, IAA
    Naim, HY
    MILCHWISSENSCHAFT-MILK SCIENCE INTERNATIONAL, 2003, 58 (5-6): : 266 - 270
  • [28] Solution structures and model membrane interactions of lactoferrampin, an antimicrobial peptide derived from bovine lactoferrin
    Haney, Evan F.
    Lau, Fanny
    Vogel, Hans J.
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2007, 1768 (10): : 2355 - 2364
  • [29] Lactoferricin but not lactoferrin inhibit herpes simplex virus type 2 infection in mice
    Shestakov, Andrey
    Jenssen, Havard
    Nordstrom, Inger
    Eriksson, Kristina
    ANTIVIRAL RESEARCH, 2012, 93 (03) : 340 - 345
  • [30] Bovine lactoferrin is more efficient than bovine lactoferricin in inhibiting HSV-I/-II replication in vitro
    Hammer, J
    Haaheim, H
    Gutteberg, TJ
    LACTOFERRIN: STRUCTURE, FUNCTION AND APPLICATIONS, 2000, 1195 : 239 - 243